Shares of Genoptix (Carlsbad, California) saw unusually high trading volume Monday, after Novartis (Basel, Switzerland) reported that it would acquire the company for $470 million. (Medical Device Daily)

Last week the company was successful in its endeavor of gaining FDA approval for this combination device, which sees the On-X Aortic Prosthesis work in tandem with Vascutek's (Ann Arbor, Michigan) Gelweave Valsalva graft. (Medical Device Daily)

Investors discussed key take home points from last week's J.P. Morgan 29th annual Healthcare Conference, during an investors conference call yesterday. For the better part of an hour analysts zeroed in on several med-tech companies citing what obstacles the firms faced in achieving growth and what the "story" would be for the companies in the next few years. (Medical Device Daily)